Carolynn Arpin

Dr. Carolynn Arpin is a Professor of Organic Chemistry in the Department of Chemistry at California State University, Chico, where she maintains an active research program focused on medicinal chemistry and synthetic methods development. Her research group, the Arpin Lab, investigates the development of innovative synthetic approaches for creating small molecules that target protein-protein interactions with therapeutic relevance.

Dr. Arpin earned her B.S. from Georgia Southern University, her Ph.D. from the University of Colorado, Boulder, and completed postdoctoral research at the University of Toronto. Her academic journey has positioned her at the intersection of organic synthesis and biological applications, with particular emphasis on cancer therapeutics.

Her research interests center around organic reaction development applied to medicinal chemistry problems, with a strong focus on STAT3 signaling pathways and their role in various cancers. Dr. Arpin's work bridges synthetic organic chemistry with translational medical research, developing novel compounds that target specific protein interactions involved in disease processes. Her laboratory actively pursues the creation of small molecule inhibitors that can disrupt pathological protein-protein interactions, particularly those relevant to cancer progression and treatment resistance.

Analysis of Dr. Arpin's publication record reveals a consistent research trajectory focused on STAT3 pathway inhibition and its applications across multiple cancer types including leukemia, pancreatic cancer, and brain tumors. Her work demonstrates expertise in both synthetic chemistry methodology and biological application, with publications spanning from fundamental synthetic approaches to translational cancer therapeutics research. The progression of her work shows increasing focus on targeted therapeutic development with clinical relevance.

Dr. Arpin has contributed to several patent applications related to salicylic acid derivatives and their therapeutic applications, demonstrating the translational potential of her research. Her collaborative approach is evident in her numerous co-authored publications with researchers from various institutions.

The Arpin Lab serves as the primary research environment for her investigations, providing students with opportunities to engage in cutting-edge medicinal chemistry research that bridges synthetic organic chemistry with biological applications. Her laboratory work supports the development of novel therapeutic approaches targeting challenging protein-protein interactions.